Yellow fever vaccin
Ended Awarded Last action
- Contract number
- SPE2DP26F0524
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,405
Award facts
- Contract value 100% obligated
- $7,404.60 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $7,404.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for yellow fever vaccine (YF-VAX) supply. The award, issued on October 30, 2025, with completion targeted for the same date, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order was executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements globally.
The PPV-G GEN V contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, has demonstrated substantial federal contracting capability through numerous delivery orders and established performance across multiple therapeutic categories. The vendor maintains no subcontractor relationships on identified awards and serves as a critical supplier within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DP26F0524?
SPE2DP26F0524 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 30, 2025.
How much is contract SPE2DP26F0524 worth?
The government has obligated $7,405 on SPE2DP26F0524.
Is contract SPE2DP26F0524 an order under another contract?
Yes. SPE2DP26F0524 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F0524 competed?
The extent of competition for SPE2DP26F0524 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award